Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models

Familial Cancer

Volumn 7, Issue 3, 2008, Pages 199-212

  Roudgari, Hassan ^a,b   Miedzybrodzka, Zosia H ^a   Haites, Neva E ^a  

^a Institute of Applied Health Sciences   (United Kingdom)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

BRCA1; BRCA2; Breast and ovarian analysis of disease incidence and carrier (BOADICEA); Breast cancer; Carrier probability; COS software; Genetic counselling; Manchester scoring system (MSS); Ovarian cancer; Probability estimation models; Tyrer Cuzick (T C)

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA2 PROTEIN;

ARTICLE; CANCER GENETICS; CLINICAL PRACTICE; FAMILY; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; UNITED KINGDOM;

AREA UNDER CURVE; BRCA1 PROTEIN; BRCA2 PROTEIN; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, GENETIC; MODELS, STATISTICAL; MUTATION; PEDIGREE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; ROC CURVE; SCOTLAND; SENSITIVITY AND SPECIFICITY; SOFTWARE;

EID: 48349127193     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9176-2     Document Type: Article

References (35)

1. Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM (2003) Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 178(2):77-81
2. Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, Blazer KR, Cullinane CA (2003) Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 138(12):1323-1328
3. Henriksson K, Olsson H, Kristoffersson U (2004) The need for oncogenetic counseling-ten years' experience of a regional oncogenetic clinic. Acta Oncologica 43(7):637-649
4. Contegiacomo A, Pensabene M, Capuano I, Tauchmanova L, Federico M, Turchetti D, Cortesi L, Marchetti P, Ricevuto E, Cianci G, Venuta S, Barbieri V, Silingardi V (2004) An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer. Ann Oncol 15(5):726-732
5. Iredale R, Elwyn G, Edwards A, Gray J (2007) Attitudes of genetic clinicians in Wales to the future development of cancer genetic services. J Eval Clin Pract 13(1):86-89
6. Schlich-Bakker KJ, ten Kroode HFJ, Ausems MGEM (2006) A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns 62(1):13-20
7. Brown P (2005) Risk assessment: controversies and management of moderate- to high-risk individuals. Breast J 11(s1):S11-S19
8. Claus EB, Risch N, Thompson WD (1994) Autosomal-dominant inheritance of early-onset breast-cancer-implications for risk prediction. Cancer 73(3):643-651
9. Murday V (1994) Genetic counselling in the cancer family clinic. Eur J Cancer 30A(13):2012-2015
10. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Haites N, Milner B, Allan L, Ponder BAJ, Peto J, Smith S, Stratton M, Lenoir GM, Feunteun J, Lynch H, Arason A, Barkardottir R, Egilsson V, Black DM, Kelsell D, Spurr N, Devilee P, Cornelisse CJ, Varsen H, Birch JM, Skolnick M, Santibanezkoref MS, Teare D, Steel M, Porter D, Cohen BB, Carothers A, Smyth E, Weber B, Newbold B, Boehnke M, Collins FS, Cannonalbright LA, Goldgar D (1994) Risks of cancer in Brca1-mutation carriers. Lancet 343(8899):692-695
11. Parmigiani G, Berry DA, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62(1):145-158
12. Claus EB, Stowe M, Carter D (2001) Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst 93(23):1811-1817
13. Antoniou AC, Pharoah PPD, Smith P, Easton DF (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91(8):1580-1590
14. Evans DGR, Eccles DM, Rahman N, Young K, Bulman M, Amir E, Shenton A, Howell A, Lalloo F (2004) A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41(6):474-480
15. Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111-1130
16. Kang HH, Williams R, Leary J, Ringland C, Kirk J, Ward R (2006) Evaluation of models to predict BRCA germline mutations. Br J Cancer 95(7):914-920
17. Claus EB, Risch N, Thompson WD (1991) Genetic-analysis of breast-cancer in the cancer and steroid-hormone study. Am J Hum Genet 48(2):232-242
18. Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40(11):807-814
19. Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898-5905
20. Evans DGR, Lalloo F, Wallace A, Rahman N (2005) Update on the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 42(7):e39
21. Roudgari H, Masson LF, Haites NE. Information recovery in cancer families: value for risk estimations. Fam Cancer 23/May/2007 (online version)
22. American Society of Clinical Oncology (1996) Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 14:1730-1736
23. American Society of Clinical Oncology (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21(12):2397-2406
24. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39(4):561-577 (published erratum appears in Clin Chem 1993 Aug; 39(8):1589)
25. Dujardin B, Vandenende J, Vangompel A, Unger JP, Vanderstuyft P (1994) Likelihood ratios-a real improvement for clinical decision-making. Eur J Epidemiol 10(1):29-36
26. Moons KGM, Vanes GA, Deckers JW, Habbema JDF, Grobbee DE (1997) Limitations of sensitivity, specificity, likelihood ratio, and Bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology 8(1):12-17
27. Obuchowski NA, Lieber ML, Wians FH Jr (2004) ROC curves in clinical chemistry: uses, misuses, and possible solutions. Clin Chem 50(7):1118-1125
28. Euhus DM, Smith KC, Robinson L, Stucky A, Olopade OI, Cummings S, Garber JE, Chittenden A, Mills GB, Rieger P, Esserman L, Crawford B, Hughes KS, Roche CA, Ganz PA, Seldon J, Fabian CJ, Klemp J, Tomlinson G (2002) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. JNCI Cancer Spectr 94(11):844-851
29. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. JNCI Cancer Spectr 91(11):943-949
30. Mallon E, Osin P, Nasiri N, Blain I, Howard B, Gusterson B (2000) The basic pathology of human breast cancer. J Mammary Gland Biol Neoplasia 5(2):139-163
31. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480-1490
32. Barcenas CH, Hosain GMM, Arun B, Zong J, Zhou X, Chen J, Cortada JM, Mills GB, Tomlinson GE, Miller AR, Strong LC, Amos CI (2006) Assessing BRCA carrier probabilities in extended families. J Clin Oncol 24(3):354-360
33. Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56(1):265-271
34. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689
35. Anderson H, Bladstrom A, Olsson H, Moller TR (2000) Familial breast and ovarian cancer: a Swedish population-based register study. Am J Epidemiol 152(12):1154-1163